Dominik Maurer

VP, Immunology & Site Head Tuebingen at Immatics

Dominik Maurer joined Immatics Biotechnologies GmbH in 2008 the Immunology department.

For 10+ years Dominik has been active in the field of cancer immunotherapy and a leader in human T-cell biology. He invented and developed with his team the Immatics’s T-Cell Receptor (TCR) technology platform XCEPTOR™ which is enabling the fast and efficient discovery, engineering and qualification of a large number of high-affinity and high-specificity TCRs that can be used for Adoptive Cell Therapies i.e. ACTengine® and ACTallo® and TCER™ - Bispecifics.

Dominik leads a global-acting Immunology department consisting of four divisions responsible for the TCR discovery platform XCEPTOR™, TCER™ - Bispecifics preclinical development, cellular & molecular Immunomonitoring, and Product Science of adoptive cell therapies.

Dominik is an inventor of 10+ patents and patent applications and has co-authored 10+ publications in peer-reviewed journals including Nature, Nature Medicine, Science Immunology, Immunity, Lancet Oncology.

Dominik Maurer gained his Ph.D. in Immunology from the University of Tuebingen, Germany.




Offices

This person is not in any offices